IP Library Patent Application 12195770
Patent Application
App. No. 12/195,770

FABRICATION OF MONOLITHIC ZONES ON POROUS SCAFFOLD

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
12/195,770
Abstract

Processes for preparing medical devices comprising building, by confocally fed, laser-assisted microdeposition, a monolithic biocompatible ceramic coating on a surface of a porous or porogenic, biocompatible substrate; medical devices prepared thereby; and kits comprising them.

Claims (35)

1 . A process for preparing a medical device that comprises a porous biocompatible substrate and a biocompatible monolithic coating on a surface thereof, the process comprising:

(A) providing

(1) a porous biocompatible substrate comprising a porous biocompatible metallic, ceramic, or glass-ceramic material;

(2) a supply of particulate raw material capable of being melt-deposited to form a biocompatible ceramic or glass-ceramic layer upon the porous substrate surface;

(3) a supply of carrier gas; and

(4) a computer-programmable, automated, laser-assisted microdeposition (LAM) device having at least one integrated deposition head, the head both comprising a laser and having at least two particle delivery nozzles, each of which is so positioned as to be capable of directing a stream of the gas carrier confocally to the focal point of the laser;

(B) placing a portion of said surface of said substrate in contact with the laser beam at its focal point;

(C) mixing particulate raw material (A 2 ) with carrier gas (A 3 ) to form a particle stream;

(D) feeding the particle stream into each of at least two of said delivery nozzles of the deposition head, whereupon the laser at least partially melts the particulate raw material delivered to the focal point;

(E) cooling the particulate raw material to form a solid deposit of biocompatible ceramic or glass-ceramic material on said portion of said surface substrate; and

(F) moving the substrate relative to the laser beam to direct the laser beam focal point, at least once, across the remainder of said surface in a predetermined pattern, while performing said mixing, feeding and cooling steps, by which a layer of biocompatible ceramic or glass-ceramic material is deposited on substantially the entirety of said surface, at least the final deposited layer thereof being a contiguous layer, thereby forming a biocompatible, monolithic ceramic or glass-ceramic coating on said surface.

2 . The process according to claim 1 , further comprising machining the device or component.

3 . The process according to claim 1 , wherein said substrate is moved across the surface area more than once to deposit more than one layer on the surface to form the coating.

4 . The process according to claim 3 , wherein all the layers are contiguous layers.

5 . The process according to claim 3 , wherein the composition of the particle stream used to form each of a sequence of layers is changed between layers or between groups of layers so as to from a chemical or physical gradient among the layers.

6 . The process according to claim 5 , wherein the particle stream composition is changed by successively increasing the volume/volume particle concentration of the particle stream.

7 . The process according to claim 5 , wherein the particle stream composition is changed by successively increasing the percent content of at least one component, and fewer than all components, in a multi-component particle stream.

8 . The process according to claim 1 , wherein the particles have an average diameter of about 0.1 to about 100 microns.

9 . The process according to claim 1 , wherein the porous substrate comprises a porous biocompatible metallic titanium, titanium alloy, cobalt-chromium alloy, tantalum, or stainless steel.

10 . The process according to claim 1 , wherein the porous substrate comprises a porous biocompatible titanium alloy.

11 . The process according to claim 10 , wherein the titanium alloy further comprises nickel, aluminum, vanadium, niobium, tantalum, zirconium, molybdenum, or a combination thereof.

12 . The process according to claim 10 , wherein the titanium alloy is a TiAl 6 V 4 alloy.

13 . The process according to claim 1 , wherein the surface of said substrate is an articulating surface.

14 . The process according to claim 1 , wherein the particulate raw material is capable of being melt-deposited to form a biocompatible ceramic or glass-ceramic layer of a porcelain, calcium phosphate compound, titania, alumina, calcium oxide, silicon carbide, silicon nitride, or combination thereof.

15 . The process of claim 14 , wherein the particulate raw material comprises titanium, titanium alloys (e.g., Ti 6 Al 4 V), Co—Cr alloys (e.g., Co—Cr—Mo alloys), stainless steel (e.g., 316L), and alloys comprising such metals.

16 . The process according to claim 1 , wherein the particulate raw material is capable of being melt-deposited to form a biocompatible layer of a hydroxyapatite compound.

17 . The process according to claim 1 , wherein for at least the first layer deposited on the substrate, the predetermined pattern of step (E) is a coordinate deposition pattern.

18 . The process according to claim 1 , wherein said process further comprises determining a coordinate deposition pattern prior to step (B).

19 . A medical device or medical device component comprising a porous biocompatible metallic, ceramic, or glass-ceramic substrate and a confocally-laser-deposited coating of biocompatible monolithic ceramic, or glass-ceramic coating on a surface thereof.

20 . A medical device according to claim 19 , wherein the coating is non-laminated and reinforces the scaffolding of the porous substrate.

21 . A medical device according to claim 19 , wherein the surface is an articulating surface.

22 . The device or component according to claim 19 , wherein the porous substrate comprises a porous biocompatible titanium alloy.

23 . The device or component according to claim 19 , wherein the coating comprises a biocompatible ceramic or glass-ceramic layer of a porcelain, calcium phosphate compound, titania, alumina, calcium oxide, silicon carbide, silicon nitride, or combination thereof.

24 . The device or component according to claim 23 , wherein the coating further comprises titanium, titanium alloys (e.g., Ti 6 Al 4 V), Co—Cr alloys (e.g., Co—Cr—Mo alloys), stainless steel (e.g., 316L), and alloys comprising such metals.

25 . The medical device according to claim 19 , wherein the coating comprises at least one coordinately deposited layer.

Assignments (3)
RELEASE OF SECURITY INTEREST IN PATENTS RECORDED AT REEL 023505/ FRAME 0241 Recorded Nov 23, 2015
From: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
To: LVB ACQUISITION, INC.; BIOMET, INC.; BIOMET 3I, LLC; BIOMET BIOLOGICS, LLC.; BIOMET EUROPE LTD.; BIOMET FAIR LAWN LLC; BIOMET HOLDINGS LTD.; BIOMET INTERNATIONAL LTD.; BIOMET LEASING, INC.; BIOMET MANUFACTURING CORPORATION; BIOMET MICROFIXATION, LLC; BIOMET ORTHOPEDICS, LLC; BIOMET SPORTS MEDICINE, LLC; BIOMET TRAVEL, INC.; BIOLECTRON, INC.; CROSS MEDICAL PRODUCTS, LLC; ELECTR-OBIOLOGY, LLC; EBI HOLDINGS, LLC; EBI, LLC; EBI MEDICAL SYSTEMS, LLC; BIOMET FLORIDA SERVICES, LLC; INTERPORE CROSS INTERNATIONAL, LLC; INTERPORE SPINE, LTD.; KIRSCHNER MEDICAL CORPORATION; IMPLANT INNOVATIONS HOLDINGS, LLC
Reel/Frame 037155/0082 →
SECURITY AGREEMENT Recorded Nov 12, 2009
From: LVB ACQUISITION, INC.; BIOMET, INC.; BIOMET 3I, LLC; BIOMET BIOLOGICS, LLC; BIOMET EUROPE LTD.; BIOMET FAIR LAWN LLC; BIOMET HOLDINGS LTD.; BIOMET INTERNATIONAL LTD.; BIOMET LEASING, INC.; BIOMET MANUFACTURING CORPORATION; BIOMET MICROFIXATION, LLC; BIOMET ORTHOPEDICS, LLC; BIOMET SPORTS MEDICINE, LLC; BIOMET TRAVEL, INC.; BIOLECTRON, INC.; CROSS MEDICAL PRODUCTS, LLC; ELECTRO-BIOLOGY, LLC; EBI HOLDINGS, LLC; EBI, LLC; EBI MEDICAL SYSTEMS, LLC; BIOMET FLORIDA SERVICES, LLC; INTERPORE CROSS INTERNATIONAL, LLC; INTERPORE SPINE, LTD.; KIRSCHNER MEDICAL CORPORATION; IMPLANT INNOVATIONS HOLDINGS, LLC
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT FOR THE SECURED PARTIES
Reel/Frame 023505/0241 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 13, 2009
From: KUMAR, MUKESH
To: BIOMET MANUFACTURING CORP.
Reel/Frame 023096/0779 →